Sun Pharma Advanced Research Company Limited (SPARC NSE) stock market data APIs
INR143.3539
2.24(1.6%)
as of September 17, 2025
Try our APIs with
free plan!
Sun Pharma Advanced Research Company Limited Financial Data Overview
Price chart is built with
Anychart
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Prev. Close
143.3539
Open
145.5903
High
145.6873
Low
144.7522
52 wk Range
109.3-241
Market Cap
46 828 M
Shares Outstanding
325 M
Revenue
646 M
EPS
-2.45
Beta
0.298
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sun Pharma Advanced Research Company Limited (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sun Pharma Advanced Research Company Limited data using free add-ons & libraries
Get Sun Pharma Advanced Research Company Limited Fundamental Data
Sun Pharma Advanced Research Company Limited Fundamental data includes:
- Net Revenue: 646 M
- EBITDA: -2 835 895 808
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Sun Pharma Advanced Research Company Limited Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-02-10
- EPS/Forecast: NaN
Get Sun Pharma Advanced Research Company Limited End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sun Pharma Advanced Research Company Limited News
New
OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway
AI-driven collaboration aims to facilitate discovery and development of innovative compounds and combination therapies in precision oncology NEW YORK, June 8, 2021 /PRNewswire/ -- OneThree Biotech to...
OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway
AI-driven collaboration aims to facilitate discovery and development of innovative compounds and combination therapies in precision oncology NEW YORK, June 8, 2021 /PRNewswire/ -- OneThree Biotech to...
Marc Miller Offers a Peek Into the Inner Workings of SPARC
SPARC is a case study in successful evolution. Originally created by Simon Property Group and Authentic Brands Group as a lifeline to fight empty storefronts in the real estate developer’s malls aro...
Marc Miller Offers a Peek Into the Inner Workings of SPARC
SPARC is a case study in successful evolution. Originally created by Simon Property Group and Authentic Brands Group as a lifeline to fight empty storefronts in the real estate developer’s malls aro...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
